New insights into the role of fibroblast growth factors in Alzheimer's disease

Mol Biol Rep. 2021 Nov 3. doi: 10.1007/s11033-021-06890-0. Online ahead of print.ABSTRACTAlzheimer's disease (AD), acknowledged as the most common progressive neurodegenerative disorder, is the leading cause of dementia in the elderly. The characteristic pathologic hallmarks of AD-including the deposition of extracellular senile plaques (SP) formation, intracellular neurofibrillary tangles, and synaptic loss, along with prominent vascular dysfunction and cognitive impairment-have been observed in patients. Fibroblast growth factors (FGFs), originally characterized as angiogenic factors, are a large family of signaling molecules that are implicated in a wide range of biological functions in brain development, maintenance and repair, as well as in the pathogenesis of brain-related disorders including AD. Many studies have focused on the implication of FGFs in AD pathophysiology. In this review, we will provide a summary of recent findings regarding the role of FGFs and their receptors in the pathogenesis of AD, and discuss the possible opportunities for targeting these molecules as novel treatment strategies in AD.PMID:34731369 | DOI:10.1007/s11033-021-06890-0
Source: Molecular Biology Reports - Category: Molecular Biology Authors: Source Type: research